glp-1 stomach paralysis legal team in kentucky Wegovy Bowel Obstruction Lawsuit Alleges Weight-Loss Injections Caused Gastroparesis kentucky glp-1 gastroparesis lawyer semaglutide

Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe pancreatitis, or uncontrolled diabetes should avoid these medications

Clinical trials show slightly greater average weight loss with tirzepatide compared to semaglutide, though individual responses vary

In a large Phase 3 clinical trial published in the New England Journal of Medicine, people who took the highest dose of the Wegovy pill lost an average of 16.6 percent of their body weight after 64 weeks

Have not taken a BP pill, Lipton, Meloxicam, or Pradulent Shot (stops body from producing cholesterol) or some crap

Emerging risk of environmental factors: insight mechanisms of Alzheimers diseases

Mulhall et al., 2022